{
    "xml": "<topic id=\"PHP4479\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/ethinylestradiol\" basename=\"ethinylestradiol\" title=\"ETHINYLESTRADIOL\">\n<title>ETHINYLESTRADIOL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_638\" namespace=\"/interactions/list-of-drug-interactions/oestrogens/ethinylestradiol\">Ethinylestradiol</xref>\n</p>\n<data name=\"vtmid\">15432003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_848193368\" title=\"Oestrogens\">Oestrogens</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">Ethinyloestradiol</p>\r\n</body>\n<topic id=\"PHP57307\" outputclass=\"indicationsAndDose\" rev=\"1.29\" parent=\"/drugs/ethinylestradiol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Short-term treatment of symptoms of oestrogen deficiency</p>\n<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis if other drugs cannot be used</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>10&#8211;50&#8239;micrograms daily for 21 days, repeated after 7-day tablet-free period, to be given with progestogen for 12&#8211;14 days per cycle in women with intact uterus.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Female hypogonadism</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>10&#8211;50&#8239;micrograms daily usually on cyclical basis, initial oestrogen therapy should be followed by combined oestrogen and progestogen therapy.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Menstrual disorders</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>20&#8211;50&#8239;micrograms daily from day 5 to 25 of each cycle, to be given with progestogen, added either throughout the cycle or from day 15 to 25.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Palliative treatment of prostate cancer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult male\">\n<p>Adult (male)</p>\n<p>0.15&#8211;1.5&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57378\" outputclass=\"contraindications\" rev=\"1.29\" parent=\"/drugs/ethinylestradiol\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"contraindication\">active or recent arterial thromboembolic disease (e.g. angina or myocardial infarction)</ph>; <ph outputclass=\"contraindication\">active thrombophlebitis</ph>; <ph outputclass=\"contraindication\">Dubin-Johnson and Rotor syndromes (or monitor closely)</ph>; <ph outputclass=\"contraindication\">gallstones</ph>; <ph outputclass=\"contraindication\">heart disease associated with pulmonary hypertension</ph>; <ph outputclass=\"contraindication\">heart disease associated with risk of embolus</ph>; <ph outputclass=\"contraindication\">history during pregnancy of cholestatic jaundice</ph>; <ph outputclass=\"contraindication\">history during pregnancy of chorea</ph>; <ph outputclass=\"contraindication\">history during pregnancy of pemphigoid gestationis</ph>; <ph outputclass=\"contraindication\">history during pregnancy of pruritus</ph>; <ph outputclass=\"contraindication\">history of breast cancer</ph>; <ph outputclass=\"contraindication\">history of haemolytic uraemic syndrome</ph>; <ph outputclass=\"contraindication\">liver disease (where liver function tests have failed to return to normal)</ph>; <ph outputclass=\"contraindication\">migraine with aura</ph>; <ph outputclass=\"contraindication\">oestrogen-dependent cancer</ph>; <ph outputclass=\"contraindication\">sclerosing treatment for varicose veins</ph>; <ph outputclass=\"contraindication\">severe or multiple risk factors for arterial disease</ph>; <ph outputclass=\"contraindication\">severe or multiple risk factors for venous thromboembolism</ph>; <ph outputclass=\"contraindication\">systemic lupus erythematosus with (or unknown) antiphospholipid antibodies</ph>; <ph outputclass=\"contraindication\">thrombophilic disorder</ph>; <ph outputclass=\"contraindication\">transient cerebral ischaemic attacks without headaches</ph>; <ph outputclass=\"contraindication\">undiagnosed vaginal bleeding</ph>; <ph outputclass=\"contraindication\">untreated endometrial hyperplasia</ph>; <ph outputclass=\"contraindication\">venous thromboembolism, or history of recurrent venous thromboembolism (unless already on anticoagulant treatment)</ph>\r\n</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP57426\" outputclass=\"cautions\" rev=\"1.25\" parent=\"/drugs/ethinylestradiol\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Active trophoblastic disease (until return to normal of urine- and plasma-gonadotrophin concentration)&#8212;seek specialist advice</ph>; <ph outputclass=\"caution\">cardiovascular disease (sodium retention with oedema, thromboembolism)</ph>; <ph outputclass=\"caution\">Crohn&#8217;s disease</ph>; <ph outputclass=\"caution\">diabetes (increased risk of heart disease)</ph>; <ph outputclass=\"caution\">gene mutations associated with breast cancer (e.g. BRCA&#8239;1)</ph>; <ph outputclass=\"caution\">history of breast nodules or fibrocystic disease&#8212;closely monitor breast status (risk of breast cancer)</ph>; <ph outputclass=\"caution\">history of endometrial hyperplasia</ph>; <ph outputclass=\"caution\">history of severe depression (especially if induced by hormonal contraceptive)</ph>; <ph outputclass=\"caution\">hyperprolactinaemia (seek specialist advice)</ph>; <ph outputclass=\"caution\">hypophyseal tumours</ph>; <ph outputclass=\"caution\">increased risk of gall-bladder disease</ph>; <ph outputclass=\"caution\">inflammatory bowel disease</ph>; <ph outputclass=\"caution\">migraine (migraine-like headaches)</ph>; <ph outputclass=\"caution\">personal or family history of hypertriglyceridaemia (increased risk of pancreatitis)</ph>; <ph outputclass=\"caution\">presence of antiphospholipid antibodies (increased risk of thrombotic events)</ph>; <ph outputclass=\"caution\">prolonged exposure to unopposed oestrogens may increase risk of developing endometrial cancer</ph>; <ph outputclass=\"caution\">risk factors for arterial disease</ph>; <ph outputclass=\"caution\">risk factors for migraine</ph>; <ph outputclass=\"caution\">risk factors for oestrogen-dependent tumours (e.g. breast cancer in first-degree relative)</ph>; <ph outputclass=\"caution\">risk factors for venous thromboembolism</ph>; <ph outputclass=\"caution\">sickle-cell disease</ph>; <ph outputclass=\"caution\">undiagnosed breast mass</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Other conditions</p>\n<p>The product literature advises caution in other conditions including hypertension, renal disease, asthma, epilepsy, sickle-cell disease, melanoma, otosclerosis, multiple sclerosis, and systemic lupus erythematosus (but care required if antiphospholipid antibodies present, see above). Evidence for caution in these conditions is unsatisfactory and many women with these conditions may stand to benefit from HRT.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Risk of venous thromboembolism</p>\n<p>Use with <b>caution</b> if any of following factors present but <b>avoid</b> if two or more factors present:</p>\n<ul>\n<li>\n<i>family history of venous thromboembolism</i> in first-degree relative aged under 45 years (avoid if known prothrombotic coagulation abnormality e.g. factor V Leiden or antiphospholipid antibodies (including lupus anticoagulant));</li>\n<li>\n<i>obesity</i>&#8212;body mass index &#8805;30&#8239;kg/m<sup>2</sup> (avoid if body mass index &#8805;35&#8239;kg/m<sup>2</sup> unless no suitable alternative); (In adolescents, caution if obese according to BMI (adjusted for age and gender); in those who are markedly obese, avoid unless no suitable alternative);</li>\n<li>\n<i>long-term immobilisation</i> e.g. in a wheelchair (avoid if confined to bed or leg in plaster cast);</li>\n<li>\n<i>history of superficial thrombophlebitis;</i>\n</li>\n<li>\n<i>age</i> over 35 years (avoid if over 50 years);</li>\n<li>\n<i>smoking.</i>\n</li>\n</ul>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Risk factors for arterial disease</p>\n<p>Use with <b>caution</b> if any one of following factors present but <b>avoid</b> if two or more factors present:</p>\n<ul>\n<li>\n<i>family history of arterial disease</i> in first degree relative aged under 45 years (avoid if atherogenic lipid profile);</li>\n<li>\n<i>diabetes mellitus</i> (avoid if diabetes complications present);</li>\n<li>\n<i>hypertension</i>&#8212;blood pressure above <i>systolic 140&#8239;mmHg</i> or <i>diastolic 90&#8239;mmHg</i> (avoid if blood pressure above <i>systolic 160&#8239;mmHg</i> or <i>diastolic 95&#8239;mmHg</i>); (In adolescents, avoid if blood pressure very high);</li>\n<li>\n<i>smoking</i> (avoid if smoking 40 or more cigarettes daily);</li>\n<li>\n<i>age</i> over 35 years (avoid if over 50 years);</li>\n<li>\n<i>obesity</i> (avoid if body mass index &#8805;35&#8239;kg/m<sup>2</sup> unless no suitable alternative); (In adolescents, caution if obese according to BMI (adjusted for age and gender); in those who are markedly obese, avoid unless no suitable alternative);</li>\n<li>\n<i>migraine without aura</i> (avoid if <i>migraine with aura</i> (focal symptoms), <i>or</i> severe migraine frequently lasting over 72 hours despite treatment, <i>or</i> migraine treated with ergot derivatives).</li>\n</ul>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Migraine</p>\n<p>Women should report any increase in headache frequency or onset of focal symptoms (discontinue immediately and refer urgently to neurology expert if focal neurological symptoms not typical of aura persist for more than 1 hour).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57286\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/ethinylestradiol\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (oestrogens).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57213\" outputclass=\"sideEffects\" rev=\"1.32\" parent=\"/drugs/ethinylestradiol\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gallstones</ph>; <ph outputclass=\"sideEffect\">systemic lupus erythematosus</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal bloating</ph>; <ph outputclass=\"sideEffect\">abdominal cramps</ph>; <ph outputclass=\"sideEffect\">absence of withdrawal bleeding</ph>; <ph outputclass=\"sideEffect\">altered blood lipids (may lead to pancreatitis)</ph>; <ph outputclass=\"sideEffect\">amenorrhoea after discontinuation</ph>; <ph outputclass=\"sideEffect\">breast enlargement</ph>; <ph outputclass=\"sideEffect\">breast secretion</ph>; <ph outputclass=\"sideEffect\">breast tenderness</ph>; <ph outputclass=\"sideEffect\">cervical erosion</ph>; <ph outputclass=\"sideEffect\">changes in libido</ph>; <ph outputclass=\"sideEffect\">changes in lipid metabolism</ph>; <ph outputclass=\"sideEffect\">changes in vaginal discharge</ph>; <ph outputclass=\"sideEffect\">chloasma</ph>; <ph outputclass=\"sideEffect\">cholestatic jaundice</ph>; <ph outputclass=\"sideEffect\">chorea</ph>; <ph outputclass=\"sideEffect\">contact lenses may irritate</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">feminising effects</ph>; <ph outputclass=\"sideEffect\">fluid retention</ph>; <ph outputclass=\"sideEffect\">glucose intolerance</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hepatic tumours</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">irritability</ph>; <ph outputclass=\"sideEffect\">leg cramps (rule out venous thrombosis)</ph>; <ph outputclass=\"sideEffect\">liver impairment</ph>; <ph outputclass=\"sideEffect\">migraine</ph>; <ph outputclass=\"sideEffect\">mood changes</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">nervousness</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">premenstrual-like syndrome</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">reduced menstrual loss</ph>; <ph outputclass=\"sideEffect\">skin reactions</ph>; <ph outputclass=\"sideEffect\">sodium retention</ph>; <ph outputclass=\"sideEffect\">symptoms of endometriosis may be exacerbated</ph>; <ph outputclass=\"sideEffect\">thrombosis (more common when factor V Leiden present or in blood groups A, B, and AB)</ph>; <ph outputclass=\"sideEffect\">uterine fibroids may increase in size</ph>; <ph outputclass=\"sideEffect\">vaginal candidiasis</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>; <ph outputclass=\"sideEffect\">weight changes</ph>; <ph outputclass=\"sideEffect\">&#8216;spotting&#8217; in early cycles</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Withdrawal bleeding</p>\n<p>Cyclical HRT (where a progestogen is taken for 12&#8211;14 days of each 28-day oestrogen treatment cycle) usually results in regular withdrawal bleeding towards the end of the progestogen. The aim of continuous combined HRT (where a combination of oestrogen and progestogen is taken, usually in a single tablet, throughout each 28-day treatment cycle) is to avoid bleeding, but irregular bleeding may occur during the early treatment stages (if it continues endometrial abnormality should be excluded and consideration given to cyclical HRT instead).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57280\" outputclass=\"pregnancy\" parent=\"/drugs/ethinylestradiol\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57445\" outputclass=\"breastFeeding\" parent=\"/drugs/ethinylestradiol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid until weaning or for 6 months after birth (adverse effects on lactation).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57335\" outputclass=\"hepaticImpairment\" parent=\"/drugs/ethinylestradiol\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4479-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ethinylestradiol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: tablet, oral suspension, capsule</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75511\" title=\"Tablet\" namespace=\"/drugs/ethinylestradiol/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85590\" namespace=\"/drugs/drospirenone-with-ethinylestradiol\" title=\"DROSPIRENONE WITH ETHINYLESTRADIOL\" count=\"1\" rel=\"backlink\">DROSPIRENONE WITH ETHINYLESTRADIOL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85600\" namespace=\"/drugs/ethinylestradiol-with-etonogestrel\" title=\"ETHINYLESTRADIOL WITH ETONOGESTREL\" count=\"1\" rel=\"backlink\">ETHINYLESTRADIOL WITH ETONOGESTREL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85601\" namespace=\"/drugs/ethinylestradiol-with-levonorgestrel\" title=\"ETHINYLESTRADIOL WITH LEVONORGESTREL\" count=\"1\" rel=\"backlink\">ETHINYLESTRADIOL WITH LEVONORGESTREL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85602\" namespace=\"/drugs/ethinylestradiol-with-norelgestromin\" title=\"ETHINYLESTRADIOL WITH NORELGESTROMIN\" count=\"1\" rel=\"backlink\">ETHINYLESTRADIOL WITH NORELGESTROMIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP94807\" namespace=\"/drugs/ethinylestradiol-with-norethisterone\" title=\"ETHINYLESTRADIOL WITH NORETHISTERONE\" count=\"1\" rel=\"backlink\">ETHINYLESTRADIOL WITH NORETHISTERONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP94806\" namespace=\"/drugs/ethinylestradiol-with-gestodene\" title=\"ETHINYLESTRADIOL WITH GESTODENE\" count=\"1\" rel=\"backlink\">ETHINYLESTRADIOL WITH GESTODENE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP94808\" namespace=\"/drugs/ethinylestradiol-with-norgestimate\" title=\"ETHINYLESTRADIOL WITH NORGESTIMATE\" count=\"1\" rel=\"backlink\">ETHINYLESTRADIOL WITH NORGESTIMATE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP94809\" namespace=\"/drugs/desogestrel-with-ethinylestradiol\" title=\"DESOGESTREL WITH ETHINYLESTRADIOL\" count=\"1\" rel=\"backlink\">DESOGESTREL WITH ETHINYLESTRADIOL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78400\" namespace=\"/treatment-summaries/sex-hormones\" title=\"Sex hormones\" count=\"3\" rel=\"backlink\">Sex hormones</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78485\" namespace=\"/treatment-summaries/contraceptives-hormonal\" title=\"Contraceptives, hormonal\" count=\"2\" rel=\"backlink\">Contraceptives, hormonal</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78591\" namespace=\"/treatment-summaries/hormones-malignant-disease\" title=\"Hormones, malignant disease\" count=\"1\" rel=\"backlink\">Hormones, malignant disease</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_638\" namespace=\"/interactions/list-of-drug-interactions/oestrogens/ethinylestradiol\" title=\"Ethinylestradiol\" count=\"1\" rel=\"link\">Ethinylestradiol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75511\" namespace=\"/drugs/ethinylestradiol/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP4479",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/ethinylestradiol",
    "basename": "ethinylestradiol",
    "title": "ETHINYLESTRADIOL",
    "interactants": [
        {
            "id": "bnf_int_638",
            "label": "Ethinylestradiol"
        }
    ],
    "vtmid": "15432003",
    "drugClassification": [
        "Oestrogens"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Ethinyloestradiol"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Short-term treatment of symptoms of oestrogen deficiency",
                        "html": "Short-term treatment of symptoms of oestrogen deficiency"
                    },
                    {
                        "textContent": "Osteoporosis prophylaxis if other drugs cannot be used",
                        "html": "Osteoporosis prophylaxis if other drugs cannot be used"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult female": [
                    {
                        "textContent": "10&#8211;50 micrograms daily for 21 days, repeated after 7-day tablet-free period, to be given with progestogen for 12&#8211;14 days per cycle in women with intact uterus.",
                        "html": "<p>10&#8211;50&#8239;micrograms daily for 21 days, repeated after 7-day tablet-free period, to be given with progestogen for 12&#8211;14 days per cycle in women with intact uterus.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Female hypogonadism",
                        "html": "Female hypogonadism"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult female": [
                    {
                        "textContent": "10&#8211;50 micrograms daily usually on cyclical basis, initial oestrogen therapy should be followed by combined oestrogen and progestogen therapy.",
                        "html": "<p>10&#8211;50&#8239;micrograms daily usually on cyclical basis, initial oestrogen therapy should be followed by combined oestrogen and progestogen therapy.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Menstrual disorders",
                        "html": "Menstrual disorders"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult female": [
                    {
                        "textContent": "20&#8211;50 micrograms daily from day 5 to 25 of each cycle, to be given with progestogen, added either throughout the cycle or from day 15 to 25.",
                        "html": "<p>20&#8211;50&#8239;micrograms daily from day 5 to 25 of each cycle, to be given with progestogen, added either throughout the cycle or from day 15 to 25.</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Palliative treatment of prostate cancer",
                        "html": "Palliative treatment of prostate cancer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult male": [
                    {
                        "textContent": "0.15&#8211;1.5 mg daily.",
                        "html": "<p>0.15&#8211;1.5&#8239;mg daily.</p>",
                        "ageGroup": "adult (male)"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "contraindications",
                "textContent": "active or recent arterial thromboembolic disease (e.g. angina or myocardial infarction)",
                "html": "active or recent arterial thromboembolic disease (e.g. angina or myocardial infarction)"
            },
            {
                "type": "contraindications",
                "textContent": "active thrombophlebitis",
                "html": "active thrombophlebitis"
            },
            {
                "type": "contraindications",
                "textContent": "Dubin-Johnson and Rotor syndromes (or monitor closely)",
                "html": "Dubin-Johnson and Rotor syndromes (or monitor closely)"
            },
            {
                "type": "contraindications",
                "textContent": "gallstones",
                "html": "gallstones"
            },
            {
                "type": "contraindications",
                "textContent": "heart disease associated with pulmonary hypertension",
                "html": "heart disease associated with pulmonary hypertension"
            },
            {
                "type": "contraindications",
                "textContent": "heart disease associated with risk of embolus",
                "html": "heart disease associated with risk of embolus"
            },
            {
                "type": "contraindications",
                "textContent": "history during pregnancy of cholestatic jaundice",
                "html": "history during pregnancy of cholestatic jaundice"
            },
            {
                "type": "contraindications",
                "textContent": "history during pregnancy of chorea",
                "html": "history during pregnancy of chorea"
            },
            {
                "type": "contraindications",
                "textContent": "history during pregnancy of pemphigoid gestationis",
                "html": "history during pregnancy of pemphigoid gestationis"
            },
            {
                "type": "contraindications",
                "textContent": "history during pregnancy of pruritus",
                "html": "history during pregnancy of pruritus"
            },
            {
                "type": "contraindications",
                "textContent": "history of breast cancer",
                "html": "history of breast cancer"
            },
            {
                "type": "contraindications",
                "textContent": "history of haemolytic uraemic syndrome",
                "html": "history of haemolytic uraemic syndrome"
            },
            {
                "type": "contraindications",
                "textContent": "liver disease (where liver function tests have failed to return to normal)",
                "html": "liver disease (where liver function tests have failed to return to normal)"
            },
            {
                "type": "contraindications",
                "textContent": "migraine with aura",
                "html": "migraine with aura"
            },
            {
                "type": "contraindications",
                "textContent": "oestrogen-dependent cancer",
                "html": "oestrogen-dependent cancer"
            },
            {
                "type": "contraindications",
                "textContent": "sclerosing treatment for varicose veins",
                "html": "sclerosing treatment for varicose veins"
            },
            {
                "type": "contraindications",
                "textContent": "severe or multiple risk factors for arterial disease",
                "html": "severe or multiple risk factors for arterial disease"
            },
            {
                "type": "contraindications",
                "textContent": "severe or multiple risk factors for venous thromboembolism",
                "html": "severe or multiple risk factors for venous thromboembolism"
            },
            {
                "type": "contraindications",
                "textContent": "systemic lupus erythematosus with (or unknown) antiphospholipid antibodies",
                "html": "systemic lupus erythematosus with (or unknown) antiphospholipid antibodies"
            },
            {
                "type": "contraindications",
                "textContent": "thrombophilic disorder",
                "html": "thrombophilic disorder"
            },
            {
                "type": "contraindications",
                "textContent": "transient cerebral ischaemic attacks without headaches",
                "html": "transient cerebral ischaemic attacks without headaches"
            },
            {
                "type": "contraindications",
                "textContent": "undiagnosed vaginal bleeding",
                "html": "undiagnosed vaginal bleeding"
            },
            {
                "type": "contraindications",
                "textContent": "untreated endometrial hyperplasia",
                "html": "untreated endometrial hyperplasia"
            },
            {
                "type": "contraindications",
                "textContent": "venous thromboembolism, or history of recurrent venous thromboembolism (unless already on anticoagulant treatment)",
                "html": "venous thromboembolism, or history of recurrent venous thromboembolism (unless already on anticoagulant treatment)"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Active trophoblastic disease (until return to normal of urine- and plasma-gonadotrophin concentration)&#8212;seek specialist advice",
                "html": "Active trophoblastic disease (until return to normal of urine- and plasma-gonadotrophin concentration)&#8212;seek specialist advice"
            },
            {
                "type": "cautions",
                "textContent": "cardiovascular disease (sodium retention with oedema, thromboembolism)",
                "html": "cardiovascular disease (sodium retention with oedema, thromboembolism)"
            },
            {
                "type": "cautions",
                "textContent": "Crohn&#8217;s disease",
                "html": "Crohn&#8217;s disease"
            },
            {
                "type": "cautions",
                "textContent": "diabetes (increased risk of heart disease)",
                "html": "diabetes (increased risk of heart disease)"
            },
            {
                "type": "cautions",
                "textContent": "gene mutations associated with breast cancer (e.g. BRCA 1)",
                "html": "gene mutations associated with breast cancer (e.g. BRCA&#8239;1)"
            },
            {
                "type": "cautions",
                "textContent": "history of breast nodules or fibrocystic disease&#8212;closely monitor breast status (risk of breast cancer)",
                "html": "history of breast nodules or fibrocystic disease&#8212;closely monitor breast status (risk of breast cancer)"
            },
            {
                "type": "cautions",
                "textContent": "history of endometrial hyperplasia",
                "html": "history of endometrial hyperplasia"
            },
            {
                "type": "cautions",
                "textContent": "history of severe depression (especially if induced by hormonal contraceptive)",
                "html": "history of severe depression (especially if induced by hormonal contraceptive)"
            },
            {
                "type": "cautions",
                "textContent": "hyperprolactinaemia (seek specialist advice)",
                "html": "hyperprolactinaemia (seek specialist advice)"
            },
            {
                "type": "cautions",
                "textContent": "hypophyseal tumours",
                "html": "hypophyseal tumours"
            },
            {
                "type": "cautions",
                "textContent": "increased risk of gall-bladder disease",
                "html": "increased risk of gall-bladder disease"
            },
            {
                "type": "cautions",
                "textContent": "inflammatory bowel disease",
                "html": "inflammatory bowel disease"
            },
            {
                "type": "cautions",
                "textContent": "migraine (migraine-like headaches)",
                "html": "migraine (migraine-like headaches)"
            },
            {
                "type": "cautions",
                "textContent": "personal or family history of hypertriglyceridaemia (increased risk of pancreatitis)",
                "html": "personal or family history of hypertriglyceridaemia (increased risk of pancreatitis)"
            },
            {
                "type": "cautions",
                "textContent": "presence of antiphospholipid antibodies (increased risk of thrombotic events)",
                "html": "presence of antiphospholipid antibodies (increased risk of thrombotic events)"
            },
            {
                "type": "cautions",
                "textContent": "prolonged exposure to unopposed oestrogens may increase risk of developing endometrial cancer",
                "html": "prolonged exposure to unopposed oestrogens may increase risk of developing endometrial cancer"
            },
            {
                "type": "cautions",
                "textContent": "risk factors for arterial disease",
                "html": "risk factors for arterial disease"
            },
            {
                "type": "cautions",
                "textContent": "risk factors for migraine",
                "html": "risk factors for migraine"
            },
            {
                "type": "cautions",
                "textContent": "risk factors for oestrogen-dependent tumours (e.g. breast cancer in first-degree relative)",
                "html": "risk factors for oestrogen-dependent tumours (e.g. breast cancer in first-degree relative)"
            },
            {
                "type": "cautions",
                "textContent": "risk factors for venous thromboembolism",
                "html": "risk factors for venous thromboembolism"
            },
            {
                "type": "cautions",
                "textContent": "sickle-cell disease",
                "html": "sickle-cell disease"
            },
            {
                "type": "cautions",
                "textContent": "undiagnosed breast mass",
                "html": "undiagnosed breast mass"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Other conditions",
                "textContent": "The product literature advises caution in other conditions including hypertension, renal disease, asthma, epilepsy, sickle-cell disease, melanoma, otosclerosis, multiple sclerosis, and systemic lupus erythematosus (but care required if antiphospholipid antibodies present, see above). Evidence for caution in these conditions is unsatisfactory and many women with these conditions may stand to benefit from HRT.",
                "html": "<p>The product literature advises caution in other conditions including hypertension, renal disease, asthma, epilepsy, sickle-cell disease, melanoma, otosclerosis, multiple sclerosis, and systemic lupus erythematosus (but care required if antiphospholipid antibodies present, see above). Evidence for caution in these conditions is unsatisfactory and many women with these conditions may stand to benefit from HRT.</p>"
            },
            {
                "type": "importantAdvice",
                "title": "Risk of venous thromboembolism",
                "textContent": "Use with caution if any of following factors present but avoid if two or more factors present:\n\nfamily history of venous thromboembolism in first-degree relative aged under 45 years (avoid if known prothrombotic coagulation abnormality e.g. factor V Leiden or antiphospholipid antibodies (including lupus anticoagulant)); obesity&#8212;body mass index &#8805;30 kg/m2 (avoid if body mass index &#8805;35 kg/m2 unless no suitable alternative); (In adolescents, caution if obese according to BMI (adjusted for age and gender); in those who are markedly obese, avoid unless no suitable alternative); long-term immobilisation e.g. in a wheelchair (avoid if confined to bed or leg in plaster cast); history of superficial thrombophlebitis; age over 35 years (avoid if over 50 years); smoking.",
                "html": "<p>Use with <b>caution</b> if any of following factors present but <b>avoid</b> if two or more factors present:</p><ul>\n<li>\n<i>family history of venous thromboembolism</i> in first-degree relative aged under 45 years (avoid if known prothrombotic coagulation abnormality e.g. factor V Leiden or antiphospholipid antibodies (including lupus anticoagulant));</li>\n<li>\n<i>obesity</i>&#8212;body mass index &#8805;30&#8239;kg/m<sup>2</sup> (avoid if body mass index &#8805;35&#8239;kg/m<sup>2</sup> unless no suitable alternative); (In adolescents, caution if obese according to BMI (adjusted for age and gender); in those who are markedly obese, avoid unless no suitable alternative);</li>\n<li>\n<i>long-term immobilisation</i> e.g. in a wheelchair (avoid if confined to bed or leg in plaster cast);</li>\n<li>\n<i>history of superficial thrombophlebitis;</i>\n</li>\n<li>\n<i>age</i> over 35 years (avoid if over 50 years);</li>\n<li>\n<i>smoking.</i>\n</li>\n</ul>"
            },
            {
                "type": "importantAdvice",
                "title": "Risk factors for arterial disease",
                "textContent": "Use with caution if any one of following factors present but avoid if two or more factors present:\n\nfamily history of arterial disease in first degree relative aged under 45 years (avoid if atherogenic lipid profile); diabetes mellitus (avoid if diabetes complications present); hypertension&#8212;blood pressure above systolic 140 mmHg or diastolic 90 mmHg (avoid if blood pressure above systolic 160 mmHg or diastolic 95 mmHg); (In adolescents, avoid if blood pressure very high); smoking (avoid if smoking 40 or more cigarettes daily); age over 35 years (avoid if over 50 years); obesity (avoid if body mass index &#8805;35 kg/m2 unless no suitable alternative); (In adolescents, caution if obese according to BMI (adjusted for age and gender); in those who are markedly obese, avoid unless no suitable alternative); migraine without aura (avoid if migraine with aura (focal symptoms), or severe migraine frequently lasting over 72 hours despite treatment, or migraine treated with ergot derivatives).",
                "html": "<p>Use with <b>caution</b> if any one of following factors present but <b>avoid</b> if two or more factors present:</p><ul>\n<li>\n<i>family history of arterial disease</i> in first degree relative aged under 45 years (avoid if atherogenic lipid profile);</li>\n<li>\n<i>diabetes mellitus</i> (avoid if diabetes complications present);</li>\n<li>\n<i>hypertension</i>&#8212;blood pressure above <i>systolic 140&#8239;mmHg</i> or <i>diastolic 90&#8239;mmHg</i> (avoid if blood pressure above <i>systolic 160&#8239;mmHg</i> or <i>diastolic 95&#8239;mmHg</i>); (In adolescents, avoid if blood pressure very high);</li>\n<li>\n<i>smoking</i> (avoid if smoking 40 or more cigarettes daily);</li>\n<li>\n<i>age</i> over 35 years (avoid if over 50 years);</li>\n<li>\n<i>obesity</i> (avoid if body mass index &#8805;35&#8239;kg/m<sup>2</sup> unless no suitable alternative); (In adolescents, caution if obese according to BMI (adjusted for age and gender); in those who are markedly obese, avoid unless no suitable alternative);</li>\n<li>\n<i>migraine without aura</i> (avoid if <i>migraine with aura</i> (focal symptoms), <i>or</i> severe migraine frequently lasting over 72 hours despite treatment, <i>or</i> migraine treated with ergot derivatives).</li>\n</ul>"
            },
            {
                "type": "importantAdvice",
                "title": "Migraine",
                "textContent": "Women should report any increase in headache frequency or onset of focal symptoms (discontinue immediately and refer urgently to neurology expert if focal neurological symptoms not typical of aura persist for more than 1 hour).",
                "html": "<p>Women should report any increase in headache frequency or onset of focal symptoms (discontinue immediately and refer urgently to neurology expert if focal neurological symptoms not typical of aura persist for more than 1 hour).</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (oestrogens).",
                "html": "<p>Appendix 1 (oestrogens).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Gallstones",
                        "html": "Gallstones",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "systemic lupus erythematosus",
                        "html": "systemic lupus erythematosus",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal bloating",
                        "html": "Abdominal bloating",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "abdominal cramps",
                        "html": "abdominal cramps",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "absence of withdrawal bleeding",
                        "html": "absence of withdrawal bleeding",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "altered blood lipids (may lead to pancreatitis)",
                        "html": "altered blood lipids (may lead to pancreatitis)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "amenorrhoea after discontinuation",
                        "html": "amenorrhoea after discontinuation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "breast enlargement",
                        "html": "breast enlargement",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "breast secretion",
                        "html": "breast secretion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "breast tenderness",
                        "html": "breast tenderness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cervical erosion",
                        "html": "cervical erosion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "changes in libido",
                        "html": "changes in libido",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "changes in lipid metabolism",
                        "html": "changes in lipid metabolism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "changes in vaginal discharge",
                        "html": "changes in vaginal discharge",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "chloasma",
                        "html": "chloasma",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cholestatic jaundice",
                        "html": "cholestatic jaundice",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "chorea",
                        "html": "chorea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "contact lenses may irritate",
                        "html": "contact lenses may irritate",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "feminising effects",
                        "html": "feminising effects",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fluid retention",
                        "html": "fluid retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "glucose intolerance",
                        "html": "glucose intolerance",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hepatic tumours",
                        "html": "hepatic tumours",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "irritability",
                        "html": "irritability",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "leg cramps (rule out venous thrombosis)",
                        "html": "leg cramps (rule out venous thrombosis)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "liver impairment",
                        "html": "liver impairment",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "migraine",
                        "html": "migraine",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "mood changes",
                        "html": "mood changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nervousness",
                        "html": "nervousness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "premenstrual-like syndrome",
                        "html": "premenstrual-like syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "reduced menstrual loss",
                        "html": "reduced menstrual loss",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "skin reactions",
                        "html": "skin reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "sodium retention",
                        "html": "sodium retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "symptoms of endometriosis may be exacerbated",
                        "html": "symptoms of endometriosis may be exacerbated",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombosis (more common when factor V Leiden present or in blood groups A, B, and AB)",
                        "html": "thrombosis (more common when factor V Leiden present or in blood groups A, B, and AB)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "uterine fibroids may increase in size",
                        "html": "uterine fibroids may increase in size",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vaginal candidiasis",
                        "html": "vaginal candidiasis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "weight changes",
                        "html": "weight changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "&#8216;spotting&#8217; in early cycles",
                        "html": "&#8216;spotting&#8217; in early cycles",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Withdrawal bleeding",
                "textContent": "Cyclical HRT (where a progestogen is taken for 12&#8211;14 days of each 28-day oestrogen treatment cycle) usually results in regular withdrawal bleeding towards the end of the progestogen. The aim of continuous combined HRT (where a combination of oestrogen and progestogen is taken, usually in a single tablet, throughout each 28-day treatment cycle) is to avoid bleeding, but irregular bleeding may occur during the early treatment stages (if it continues endometrial abnormality should be excluded and consideration given to cyclical HRT instead).",
                "html": "<p>Cyclical HRT (where a progestogen is taken for 12&#8211;14 days of each 28-day oestrogen treatment cycle) usually results in regular withdrawal bleeding towards the end of the progestogen. The aim of continuous combined HRT (where a combination of oestrogen and progestogen is taken, usually in a single tablet, throughout each 28-day treatment cycle) is to avoid bleeding, but irregular bleeding may occur during the early treatment stages (if it continues endometrial abnormality should be excluded and consideration given to cyclical HRT instead).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not known to be harmful.",
                "html": "<p>Not known to be harmful.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid until weaning or for 6 months after birth (adverse effects on lactation).",
                "html": "<p>Avoid until weaning or for 6 months after birth (adverse effects on lactation).</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "tablet",
                "oral suspension",
                "capsule"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75511",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85590",
                "label": "DROSPIRENONE WITH ETHINYLESTRADIOL",
                "type": "drug"
            },
            {
                "id": "PHP85600",
                "label": "ETHINYLESTRADIOL WITH ETONOGESTREL",
                "type": "drug"
            },
            {
                "id": "PHP85601",
                "label": "ETHINYLESTRADIOL WITH LEVONORGESTREL",
                "type": "drug"
            },
            {
                "id": "PHP85602",
                "label": "ETHINYLESTRADIOL WITH NORELGESTROMIN",
                "type": "drug"
            },
            {
                "id": "PHP94807",
                "label": "ETHINYLESTRADIOL WITH NORETHISTERONE",
                "type": "drug"
            },
            {
                "id": "PHP94806",
                "label": "ETHINYLESTRADIOL WITH GESTODENE",
                "type": "drug"
            },
            {
                "id": "PHP94808",
                "label": "ETHINYLESTRADIOL WITH NORGESTIMATE",
                "type": "drug"
            },
            {
                "id": "PHP94809",
                "label": "DESOGESTREL WITH ETHINYLESTRADIOL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78400",
                "label": "Sex hormones",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78485",
                "label": "Contraceptives, hormonal",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78591",
                "label": "Hormones, malignant disease",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_638",
                "label": "Ethinylestradiol",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75511",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}